Silk Road Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	380	479	1,346	1,343	1,460	1,138
Depreciation & Amortization	534	555	561	578	597	599
Loss (Gain) From Sale of Assets	-	-	-56	-	-	-
Stock-Based Compensation	135	112	39	37	38	35
Other Operating Activities	-229	-121	-101	-77	40	20
Change in Accounts Receivable	-42	43	-129	-32	-1	41
Change in Inventory	-152	-132	23	-82	-136	43
Change in Accounts Payable	157	266	105	25	68	10
Change in Other Net Operating Assets	-197	-17	127	-113	136	140
Operating Cash Flow	586	1,185	1,915	1,679	2,202	2,026
Operating Cash Flow Growth	-68.10%	-38.12%	14.06%	-23.75%	8.69%	-
Capital Expenditures	-439	-380	-290	-251	-277	-271
Divestitures	-	-	60	-	-	-
Investment in Securities	-	-	-	-	-	469
Other Investing Activities	-5	-	-	-2	-1	30
Investing Cash Flow	-444	-380	-230	-253	-278	228
Long-Term Debt Issued	-	8,303	-	-	-	-
Long-Term Debt Repaid	-	-300	-	-	-	-445
Net Debt Issued (Repaid)	-500	8,003	-	-	-	-445
Other Financing Activities	-55	-8,243	-1,552	-1,460	-1,960	-1,766
Financing Cash Flow	-555	-240	-1,552	-1,460	-1,960	-2,211
Foreign Exchange Rate Adjustments	10	3	-	4	3	-3
Net Cash Flow	-405	568	133	-30	-33	40
Free Cash Flow	147	805	1,625	1,428	1,925	1,755
Free Cash Flow Growth	-90.35%	-50.46%	13.80%	-25.82%	9.69%	-
Free Cash Flow Margin	1.75%	9.75%	19.82%	17.57%	23.56%	24.10%
Free Cash Flow Per Share	0.84	4.63	9.41	8.27	-	-
Cash Interest Paid	287	287	-	-	-	-
Cash Income Tax Paid	244	244	-	-	-	-
Levered Free Cash Flow	288.38	1,295	1,625	1,257	-	-
Unlevered Free Cash Flow	551.5	1,525	1,625	1,257	-	-
Change in Working Capital	-234	160	126	-202	67	234

Source: S&P Global Market Intelligence. Standard template. Financial Sources.